\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
ProgrammesYou can now register for the European Week of Regions and Cities 2024 with its motto "Empowering Communities," taking place in Brussels from 7 to 10 October 2024.
Get ready to exchange ideas, connect with regions and cities across Europe, and expand your network and knowledge while keeping up with the latest regional and cohesion policy developments.
Explore over 100 sessions, including EU sessions, political workshops, participatory labs and brief innovative formats, falling under four themes:
• Competitiveness and convergence: two sides of the same coin
• Regions strengthening European democracy
• Smart and sustainable growth for regions
• Regions got talent
You can find more information and register for this event at the dedicated event page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
Research Infrastructures Culture and society Climate, Energy, Mobility
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
